82_FR_18066 82 FR 17995 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review [email protected] The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry."> [email protected] The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry." /> [email protected] The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry." />

82 FR 17995 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 71 (April 14, 2017)

Page Range17995-17996
FR Document2017-07595

This publication corrects a notice that was published in the Federal Register on April 4, 2017, Volume 82, Number 63, page 16403. The meeting announcement, meeting date, and matters for discussion should read as follows: The meeting announced below concerns the Centers for Disease Control and Prevention (CDC) initial review of applications in response to Funding Opportunity Announcements GH17-002, Program Development and Research to Establish and Evaluate Innovative and Emerging Best Practices in Clinical and Community Services through the President's Emergency Plan for AIDS Relief (PEPFAR); and GH17-003, Conducting Public Health Research in South Africa. Time and Date: 9:00 a.m.-2:00 p.m., EDT, April 25, 2017, Panel A (Closed). Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ``Program Development and Research to Establish and Evaluate Innovative and Emerging Best Practices in Clinical and Community Services through the President's Emergency Plan for AIDS Relief (PEPFAR)'', FOA GH17-002; and ``Conducting Public Health Research in South Africa'', FOA GH17-003. For Further Information Contact: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: (404) 639-4796, [email protected] The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Federal Register, Volume 82 Issue 71 (Friday, April 14, 2017) 
[Federal Register Volume 82, Number 71 (Friday, April 14, 2017)]
[Notices]
[Pages 17995-17996]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-07595]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns the Centers for Disease 
Control and Prevention (CDC) initial review of applications in response 
to Funding Opportunity Announcement (FOA) GH17-002, Program Development 
and Research to Establish and Evaluate Innovative and Emerging Best 
Practices in Clinical and Community Services through the Presidents 
Emergency Plan for AIDS Relief (PEPFAR); GH17-003,

[[Page 17996]]

Conducting Public Health Research in South Africa; GH17-004, Conducting 
Public Health Research Activities in Egypt.
    Summary: This publication corrects a notice that was published in 
the Federal Register on April 4, 2017, Volume 82, Number 63, page 
16403. The meeting announcement, meeting date, and matters for 
discussion should read as follows:
    The meeting announced below concerns the Centers for Disease 
Control and Prevention (CDC) initial review of applications in response 
to Funding Opportunity Announcements GH17-002, Program Development and 
Research to Establish and Evaluate Innovative and Emerging Best 
Practices in Clinical and Community Services through the President's 
Emergency Plan for AIDS Relief (PEPFAR); and GH17-003, Conducting 
Public Health Research in South Africa.
    Time and Date: 9:00 a.m.-2:00 p.m., EDT, April 25, 2017, Panel A 
(Closed).
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Program Development and Research to Establish and Evaluate 
Innovative and Emerging Best Practices in Clinical and Community 
Services through the President's Emergency Plan for AIDS Relief 
(PEPFAR)'', FOA GH17-002; and ``Conducting Public Health Research in 
South Africa'', FOA GH17-003.
    For Further Information Contact: Hylan Shoob, Scientific Review 
Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 
Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: 
(404) 639-4796, [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-07595 Filed 4-13-17; 8:45 am]
BILLING CODE 4163-18-P

Federal Register / Vol. 82, No. 71 / Friday, April 14, 2017 / Notices 17995 FOR FURTHER INFORMATION CONTACT: Committees the name of the recipient • 1,1-Dichloro-1-Fluoroethane (HCFC– Theresa Kingsberry, Program Support and subrecipient; a brief description of 141b): https://www.cdc.gov/niosh/ Specialist, Federal Trade Commission the activity, including its purpose; and docs/2016-168/ Premerger Notification Office, Bureau of the amount of the award. • Chloroacetyl Chloride: https:// Competition, Room CC–5301, In the Federal Register notice of www.cdc.gov/niosh/docs/2016-169/ Washington, DC 20024, (202) 326–3100. March 14, 2017, at 82 FR 13607, the • Chlorine Pentafluoride: https:// By direction of the Commission. Council provided notice of a proposed www.cdc.gov/niosh/docs/2016-170/ Donald S. Clark, subaward from NOAA to GOMA for the • Furan: https://www.cdc.gov/niosh/ purpose of supporting CMAP in docs/2016-171/ Secretary. [FR Doc. 2017–07541 Filed 4–13–17; 8:45 am] accordance with the Council Monitoring • Hexafluoroacetone: https:// & Assessment Program Development www.cdc.gov/niosh/docs/2016-172/ • n-Butyl Acrylate: https:// BILLING CODE 6750–01–P award; however, the March 14, 2017 notice inadvertently omitted the amount www.cdc.gov/niosh/docs/2016-173/ of the proposed subaward to GOMA. • Butane: https://www.cdc.gov/niosh/ GULF COAST ECOSYSTEM The amount of the proposed subaward docs/2016-174/ RESTORATION COUNCIL from NOAA to GOMA under the • Benzontrile: https://www.cdc.gov/ Council Monitoring & Assessment niosh/docs/2017-104/ [Docket Number: 104142017–1111–11] Program Development award is • Methyl Isocynate: https:// Notice of Proposed Subaward Under a $525,000. www.cdc.gov/niosh/docs/2017-105/ Council-Selected Restoration Will D. Spoon, • Bromine Pentafluoride: https:// Component Award Program Analyst, Gulf Coast Ecosystem www.cdc.gov/niosh/docs/2017-106/ Restoration Council. • 1,3-Butadiene: https://www.cdc.gov/ AGENCY: Gulf Coast Ecosystem niosh/docs/2017-107/ Restoration Council. [FR Doc. 2017–07562 Filed 4–13–17; 8:45 am] • Diketene: https://www.cdc.gov/niosh/ BILLING CODE 6560–58–P ACTION: Notice; correction. docs/2017-108/ FOR FURTHER INFORMATION CONTACT: G. SUMMARY: The Gulf Coast Ecosystem Restoration Council (Council) published Scott Dotson, NIOSH/Education and a document in the Federal Register on DEPARTMENT OF HEALTH AND Information Division, 1090 Tusculum March 14, 2017 to provide notice of a HUMAN SERVICES Ave., MS C–32, Cincinnati, OH 45226, proposed subaward from the National email address: fya8@cdc.gov. Centers for Disease Control and SUPPLEMENTARY INFORMATION: On May 1, Oceanic and Atmospheric Prevention 2015, NIOSH published a request for Administration (NOAA) to the Gulf of Mexico Alliance (GOMA), a nonprofit public review in the Federal Register [CDC–2015–0020; Docket Number NIOSH [80 FR 24930] on immediately organization, for the purpose of 156–A] dangerous to life and health (IDLH) supporting the Council Monitoring and Assessment Program (CMAP) in values and support technical Issuance of Final Guidance accordance with the Council Monitoring documents. All comments received Publications & Assessment Program Development were reviewed and accepted where award as approved in the Initial Funded AGENCY: National Institute for appropriate. Priority List. The March 14, 2017 notice Occupational Safety and Health John Howard, did not include the amount of the (NIOSH) of the Centers for Disease Director, National Institute for Occupational proposed subaward. Through this Control and Prevention (CDC), Safety and Health, Centers for Disease Control correction, the Council publishes the Department of Health and Human and Prevention. amount of the proposed subaward. Services (HHS). [FR Doc. 2017–07523 Filed 4–13–17; 8:45 am] FOR FURTHER INFORMATION CONTACT: ACTION: Notice of issuance of final BILLING CODE 4163–19–P Please send questions by email to guidance publications. raams_pgmsupport@restorethegulf.gov. SUMMARY: NIOSH announces the DEPARTMENT OF HEALTH AND SUPPLEMENTARY INFORMATION: Section availability of the following final 14 HUMAN SERVICES 1321(t)(2)(E)(ii)(III) of the RESTORE Act IDLH Value Profiles: Iron (33 U.S.C. 1321(t)(2)(E)(ii)(III)) and Pentacarbonyl, Acrylonitrile, 1,1- Treasury’s implementing regulation at Centers for Disease Control and Dichloro-1-Fluoroethane (HCFC–141b), Prevention 31 CFR 34.401(b) require that, for Chloroacetyl Chloride, Chlorine purposes of awards made under the Pentafluoride, Furan, Disease, Disability, and Injury Council-Selected Restoration Hexafluoroacetone, n-Butyl Acrylate, Prevention and Control Special Component, a State or Federal award Benzontrile, Methyl Isocyanate, Emphasis Panel (SEP): Initial Review recipient may make a grant or subaward Bromine Pentafluoride, 1,3-Butadiene, to or enter into a cooperative agreement Diketene and Butane. The meeting announced below with a nongovernmental entity that concerns the Centers for Disease Control DATES: The final IDLH documents were equals or exceeds 10 percent of the total and Prevention (CDC) initial review of amount of the award provided to the published on October 5 and December applications in response to Funding sradovich on DSK3GMQ082PROD with NOTICES State or Federal award recipient only if 16, 2016. Opportunity Announcement (FOA) certain notice requirements are met. ADDRESSES: These documents may be GH17–002, Program Development and Specifically, at least 30 days before the obtained at the following links: Research to Establish and Evaluate State or Federal award recipient enters • Iron Pentacarbonyl: https:// Innovative and Emerging Best Practices into such an agreement, the Council www.cdc.gov/niosh/docs/2016-166/ in Clinical and Community Services must publish in the Federal Register • Acrylonitrile: https://www.cdc.gov/ through the Presidents Emergency Plan and deliver to specified Congressional niosh/docs/2016-167/ for AIDS Relief (PEPFAR); GH17–003, VerDate Sep<11>2014 16:21 Apr 13, 2017 Jkt 241001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\14APN1.SGM 14APN1

17996 Federal Register / Vol. 82, No. 71 / Friday, April 14, 2017 / Notices Conducting Public Health Research in DEPARTMENT OF HEALTH AND Georgia 30329, telephone (404) 639– South Africa; GH17–004, Conducting HUMAN SERVICES 8317; Email: zkr7@cdc.gov. Public Health Research Activities in The Director, Management Analysis Egypt. Centers for Disease Control and and Services Office, has been delegated Prevention the authority to sign Federal Register Summary: This publication corrects a Notices pertaining to announcements of notice that was published in the Federal Health Resources and Services meetings and other committee Register on April 4, 2017, Volume 82, Administration management activities, for both the Number 63, page 16403. The meeting Centers for Disease Control and announcement, meeting date, and CDC/HRSA Advisory Committee on Prevention and the Agency for Toxic matters for discussion should read as HIV, Viral Hepatitis and STD Prevention Substances and Disease Registry. follows: and Treatment Elaine L. Baker, The meeting announced below In accordance with section 10(a)(2) of Director, Management Analysis and Services concerns the Centers for Disease Control the Federal Advisory Committee Act Office, Centers for Disease Control and and Prevention (CDC) initial review of (Pub. L. 92–463), the Centers for Disease Prevention. applications in response to Funding Control and Prevention (CDC) and the [FR Doc. 2017–07593 Filed 4–13–17; 8:45 am] Opportunity Announcements GH17– Health Resources and Services BILLING CODE 4163–18–P 002, Program Development and Administration (HRSA) announce the Research to Establish and Evaluate following committee meeting. Innovative and Emerging Best Practices Times and Dates: 8:30 a.m.–5:00 p.m., DEPARTMENT OF HEALTH AND in Clinical and Community Services EDT, May 10, 2017; 8:30 a.m.–3:00 p.m., HUMAN SERVICES through the President’s Emergency Plan EDT, May 11, 2017. for AIDS Relief (PEPFAR); and GH17– Place: CDC Corporate Square, Centers for Disease Control and 003, Conducting Public Health Research Building 8, Conference Room 1–ABC, 8 Prevention in South Africa. Corporate Boulevard, Atlanta, Georgia Healthcare Infection Control Practices Time and Date: 9:00 a.m.–2:00 p.m., 30329, Telephone: (404) 639–8317. The Advisory Committee (HICPAC) EDT, April 25, 2017, Panel A (Closed). meeting is also accessible by teleconference. Toll-free number 1–877– In accordance with section 10(a)(2) of Matters for Discussion: The meeting 603–4228, Participant code: 42598858. the Federal Advisory Committee Act will include the initial review, Status: Open to the public, limited (Pub. L. 92–463), the Centers for Disease discussion, and evaluation of only by the space available. The meeting Control and Prevention (CDC), National applications received in response to room will accommodate approximately Center for Emerging and Zoonotic ‘‘Program Development and Research to 100 people. Persons who desire to make Infectious Diseases (NCEZID) announces Establish and Evaluate Innovative and an oral statement, may request it at the a meeting of the aforementioned Emerging Best Practices in Clinical and time of the public comment period on committee: Community Services through the May 10, 2017 at 4:30 p.m., EDT. Public Time and Date: 1:00 p.m.–2:30 p.m., President’s Emergency Plan for AIDS participation and ability to comment EDT, May 5, 2017. Relief (PEPFAR)’’, FOA GH17–002; and will be limited to space and time as it Place: This meeting will be accessible ‘‘Conducting Public Health Research in permits. by teleconference. Toll-free +1 (888) South Africa’’, FOA GH17–003. Purpose: This committee is charged 469–1070, Participant Code: 3132529. with advising the Director, CDC and the Status: Open to the public limited For Further Information Contact: Administrator, HRSA, regarding only by the availability of 200 telephone Hylan Shoob, Scientific Review Officer, activities related to prevention and ports. To register for this call, please go Center for Global Health (CGH) Science control of HIV/AIDS, Viral Hepatitis and to www.cdc.gov/hicpac. Office, CGH, CDC, 1600 Clifton Road other STDs, the support of health care Purpose: The Committee is charged NE., Mailstop D–69, Atlanta, Georgia services to persons living with HIV/ with providing advice and guidance to 30033, Telephone: (404) 639–4796, AIDS, and education of health the Director, Division of Healthcare HSHOOB@CDC.GOV. professionals and the public about HIV/ Quality Promotion, the Director, The Director, Management Analysis AIDS, Viral Hepatitis and other STDs. National Center for Emerging and and Services Office, has been delegated Matters for Discussion: Agenda items Zoonotic Infectious Diseases (NCEZID), the authority to sign Federal Register include the following topics: (1) HIV the Director, CDC, the Secretary, Health notices pertaining to announcements of transmission risk in the context of viral and Human Services regarding (1) the meetings and other committee suppression and antiretroviral therapy practice of healthcare infection management activities, for both the (ART) use; (2) Update on Pre-Exposure prevention and control; (2) strategies for Prophylaxis (PrEP) utilization; (3) surveillance, prevention, and control of Centers for Disease Control and Vulnerable youth at risk for HIV, STDs, infections, antimicrobial resistance, and Prevention and the Agency for Toxic hepatitis, substance use and other related events in settings where Substances and Disease Registry. health outcomes; (4) Eliminating healthcare is provided; and (3) periodic Elaine L. Baker, hepatitis B and hepatitis C as public updating of CDC guidelines and other Director, Management Analysis and Services health threats in the United States— policy statements regarding prevention sradovich on DSK3GMQ082PROD with NOTICES Office, Centers for Disease Control and Setting Goals and Taking Action; and (5) of healthcare-associated infections and Prevention. Updates from Workgroups. Agenda healthcare-related conditions. [FR Doc. 2017–07595 Filed 4–13–17; 8:45 am] items are subject to change as priorities Matters for Discussion: The agenda dictate. will include a follow-up discussion on BILLING CODE 4163–18–P Contact Person for More Information: the Draft Recommendation Update for Margie Scott-Cseh, Centers for Disease Chlorhexidine Impregnated Dressings. Control and Prevention, 1600 Clifton Call materials will be made available to Road NE., Mailstop E–07, Atlanta, the public no later than 2 business days VerDate Sep<11>2014 16:21 Apr 13, 2017 Jkt 241001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\14APN1.SGM 14APN1


Document Created: 2017-04-14 00:56:10
Document Modified: 2017-04-14 00:56:10
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
Dates9:00 a.m.-2:00 p.m., EDT, April 25, 2017, Panel A (Closed).
ContactHylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: (404) 639-4796, [email protected]
FR Citation82 FR 17995 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR